This study shows enhanced gamma-ray shielding in zirconium dioxide reinforced aluminum matrix composites, suggesting potential in aerospace and medical fields.
Aluminum-based metal matrix composites (Al-MMCs) reinforced with ceramic particles have garnered considerable attention due to their unique combination of low density, high mechanical strength, and good ductility. In this study, Al-MMCs reinforced with zirconium dioxide (ZrO₂) particles were fabricated via the stir casting technique to evaluate their gamma-ray (γ-ray) shielding capabilities. Three composite samples containing 5 wt%, 10 wt%, and 15 wt% ZrO₂ (denoted as AlMFCSZr-5, AlMFCSZr-10, and AlMFCSZr-15, respectively) were prepared. ZrO₂ was selected as the reinforcing phase owing to its high atomic number, chemical stability, and favorable interaction with γ-radiation. Microstructural analysis using optical microscopy confirmed the uniform distribution of ZrO₂ particles within the aluminum matrix, while X-ray diffraction (XRD) verified the structural integrity and phase stability of the composites. Gamma-ray shielding performance was assessed using both the Monte Carlo N-Particle (MCNP) simulation code and the Phy-X/PSD software. The results showed that the linear attenuation coefficient (LAC) increased with increasing ZrO₂ content, with the AlMFCSZr-15 composite exhibiting the highest shielding effectiveness. Specifically, AlMFCSZr-15 demonstrated higher value of the LAC (0.072) at an energy of 15 MeV as compared with base alloy (0.057) representing an approximately 26.3% improvement. These findings confirm the potential of ZrO₂-reinforced Al-MMCs as promising candidates for lightweight radiation shielding applications in aerospace, nuclear, and medical industries.
No takes yet. Share an insight, caveat, or question.
Waleed Mohrez (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: